Occurrence of thrombosis in congenital thrombocytopenic disorders: A critical annotation of the literature

Blood Coagulation and Fibrinolysis

Volumn 24, Issue 1, 2013, Pages 18-22

  Girolami, Antonio ^a   Sambado, Luisa ^a   Bonamigo, Emanuela ^a   Vettore, Silvia ^a   Lombardi, Anna M ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

arterial thrombosis; congenital platelet disorders; venous thrombosis

Indexed keywords

GLYCOPROTEIN IB ALPHA; JANUS KINASE 2;

ACUTE CORONARY SYNDROME; ARTERY THROMBOSIS; ARTICLE; BERNARD SOULIER DISEASE; BRAIN ISCHEMIA; DEEP VEIN THROMBOSIS; GLANZMANN DISEASE; HEART INFARCTION; HETEROZYGOSITY; HUMAN; INTRACARDIAC THROMBOSIS; LUNG EMBOLISM; META ANALYSIS; OCCLUSIVE CEREBROVASCULAR DISEASE; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; UNSTABLE ANGINA PECTORIS; VEIN THROMBOSIS;

ADULT; AGED; BERNARD-SOULIER SYNDROME; BRAIN ISCHEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; MOLECULAR MOTOR PROTEINS; MYOCARDIAL INFARCTION; MYOSIN HEAVY CHAINS; THROMBASTHENIA; THROMBOCYTOPENIA; THROMBOPHILIA; THROMBOSIS; VENOUS THROMBOSIS;

EID: 84871739326     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283597634     Document Type: Article

References (29)

1. George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990; 75:1383-1395. (Pubitemid 20114873)
2. D'Oiron R, Ménart C, Trzeciak MC, Nurden P, Fressinaud E, Dreyfus M, et al. Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures. Thromb Haemost 2000; 83:644-647. (Pubitemid 30248506)
3. Ten Cate H, Brandjes DP, Smits PH, van Mourik JA. The role of platelets in venous thrombosis: a patient with Glanzmann's thrombasthenia and a factor V Leiden mutation suffering from deep venous thrombosis. J Thromb Haemost 2003; 1:394-395.
4. McDunn S, Hartz W Jr, Ts'Ao C, Green D. Coronary thrombosis in a patient with May-Hegglin anomaly. Am J Clin Pathol 1991; 95:715-718.
5. Varbella F, Bongioanni S, Gagnor A, Nannini C, La Brocca A, Badalì A, et al. Primary angioplasty in a patient with the May-Hegglin anomaly, a rare heredity thrombocytopenia. A case report and review of the literature. Ital Heart J 2005; 6 (Suppl):214-217. (Pubitemid 41825643)
6. Goto S, Kasahara H, Sakai H, Goto M, Ono M, Ikeda Y, et al. Functional compensation of the low platelet count by increased individual platelet size in a patient with May-Hegglin anomaly presenting with acute myocardial infarction. Int J Cardiol 1998; 64:171-177. (Pubitemid 28275557)
7. Serenty M, Senadheera N, Miller E, Keeling D. Pulmonary embolus in Glanzmann's thrombasthenia treated with warfarin. Haemophilia 2008; 14:1138-1139.
8. Tullu MS, Vaideeswar P, Pandit SP, Lahiri KR. Glanzmann thrombasthenia with endomyocardial fibrosis: a thrombotic paradox. Int J Cardiol 2007; 114:401-402. (Pubitemid 44855897)
9. Humphries JE, Yirinec BA, Hess CE. Atherosclerosis and unstable angina in Bernard-Soulier syndrome. Am J Clin Pathol 1992; 97:652-655.
10. Heller PG, Pecci A, Glembotsky AC, Savoia A, Negro FD, Balduini CL, et al. Unexplained recurrent venous thrombosis in a patient with MYH9-related disease. Platelets 2006; 17:274-275. (Pubitemid 43890799)
11. Seri M, Pecci A, Di Bari F, Cusano R, Savino M, Panza E, et al. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome. Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 2003; 82:203-215. (Pubitemid 36578709)
12. Girolami A, Vettore S, Bonamigo E, Fabris F. Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old May-Hegglin, Sebastian, Fechtner and Epstein syndromes). J Thromb Thrombolysis 2011; 32:474-477.
13. Alamelu J, Liesner R. Modern management of severe platelet function disorders. Br J Haematol 2010; 149:813-823.
14. Salles II, Feys HB, Iserbyt BF, De Meyer SF, Vanhoorelbeke K, Deckmyn H. Inherited traits affecting platelet function. Blood Rev 2008; 22:155-172; Review.
15. Cattaneo M. Inherited platelet-based bleeding disorders [review]. J Thromb Haemost 2003; 1:1628-1636.
16. Nair S, Ghosh K, Kulkarni B, Shetty S, Mohenty D. Glanzmann's thromboasthenia: updated. Platelets 2007; 13:387-393.
17. Everlien M, Knoch K, Farah I, Greve H. Coronary bypass surgery in May-Hegglin anomaly. Dtsch Med Wochenschr 2001; 126:47-49. (Pubitemid 32099315)
18. Fabris F, Scandellari R, Vettore S, Scapin M, Bizzaro N, Randi ML. Intriguing outcome of JAK2V617F mutation seen in a patient with MYH9-related hereditary macrothrombocytopenia. Thromb Haemost 2010; 104:858-859.
19. Girolami A, Vettore S, Vianello F, Berti de Marinis G, Fabris F. Myocardial infarction in two cousins heterozygous for Asn41His autosomal dominant variant of Bernard-Soulier syndrome. J Thromb Thrombolysis 2012. doi:10.1007/s11239-012-0742-6.
20. Gruel Y, Pacouret G, Bellucci S, Caen J. Severe proximal deep vein thrombosis in a Glanzmann thrombasthenia variant successfully treated with a low molecular weight heparin. Blood 1997; 90:888-890. (Pubitemid 27299131)
21. Nishiyama Y, Akaishi J, Katsumata T, Katsura K, Katayama Y. Cerebral infarction in a patient with macrothrombocytopenia with leukocyte inclusions (MTCP, May-Hegglin anomaly/Sebastian syndrome). J Nihon Med Sch 2008; 75:228-232.
22. Phillips R, RichardsM.Venous thrombosis inGlanzmann's thrombasthenia. Haemophilia 2007; 13:758-759.
23. Rezende SM. Secondary prophylaxis with warfarin for recurrent thrombosis in a patient with Glanzmann thrombasthenia and F5 G1691A. Br J Haematol 2012; 156:144-145.
24. Glanzmann E. Hereditary congenital thrombasthenia: a study on the patology of blood platelets. J Kinder Kranken 1918; 88:113-120.
25. Bernard J, Soulier JP. About a new variant of congenital hemorrhagic platelet dystrophy. Sem Hop Paris 1948; 24:2317-2322.
26. Kilincaslan H, Leblebisatan G, Tepeler A, Karakus SC. Formation of obstructing blood clot in the ureter in a patient with Glanzmann's thrombasthenia. Blood Coagul Fibrinolysis 2011; 22:735-737.
27. Robinson Kl, Savoia H, Street AM. Thrombotic complications in two patients receiving Novo seven [abstract]. Haemophilia 2000; 6:3103.
28. Poon MC. Clinical ise of recombinant human activated factor VII (rF gIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombohastenia. Vascular Health Risk Manag 2007; 3:655-664.
29. Nurden AT, Nurden P, George JN. Are patients with Glanzmann thrombasthenia and the Bernard-Soulier syndrome protected against atherosclerosis? Adv Exp Med Biol 2001; 489:13-29. (Pubitemid 32374630)